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The demonstration of direct genetic control of specific immune responses followed 
the introduction of synthetic polypeptides as experimental antigens (14). The use of 
synthetic antigens, whose complexity can be controlled by varying the number and 
relative proportions of their constituent amino acids (5),  has  in  fact led to  several 
demonstrations of unigenic control of specific immune  responsiveness (6).  Thus,  the 
ability of guinea pigs to mount immune responses to poly-L-lysine (PLL)  1 and hapten 
conjugates of this polymer is determined by a  single autosomal  dominant gene, the 
"PLL gene" (1, 7, 8). In mice the immune response to GLA5, a random linear polymer 
of L-glutamic acid and  L-lysine containing 5%  L-alanine, is under  the  control of a 
dominant gene  (2).  Also in mice,  the  immunogenicity of  three branched  synthetic 
polypeptides containing random  sequences of L-glutamic acid with either L-tyrosine, 
L-histidine, or L-phenylalanine on  a  backbone of DL-atanine and  L-lysine  is largely 
determined by three single dominant genes forming the It-1  locus (3,  9,  10).  Subse- 
quently, single gene control of immune responses to more complex native antigens has 
also been observed when limiting immunizing doses are used to decrease the interac- 
tions between complex antigens and the immune system (11). 
The  relative rapidity with  which  "immune  response  genes"  have  been  demon- 
strated after the initial identification of the PLL gene suggests that there may well be 
many more of these genes yet to be discovered. The identification of several immune 
response genes within a  single species should permit preliminary mapping  of  these 
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1  Abbreviations used in this paper: GA, poly-~-(L-glutamic  acid [60%], L-alanine [40%]); 
GAT, poly-a-(L-glutamic acid [60%], L-alanine  [30~],  L-tyrosine  [10%]);  GLAs,  random 
linear polymer of  L-glutamic  acid and  L-lysine containing 5%  L-alanine;  GT,  poly-~-(L- 
glutamic acid [50%], L-tyrosine [50%]); PBS, 0.015 M phosphate buffer, pH 7.5, containing 
0.15 M NaC1; PLL, poly-L-lysine. 
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genes. Furthermore, studies on the functional interactions of several immune response 
genes will, hopefully, result in a  clearer understanding of the influence of these genes 
on immune responses to the more complex naturMly occurring antigens. With these 
objectives in mind, we have examined the immunogenicity in guinea pigs of several 
synthetic polypeptides.  We  report  here  on the  nature of  the immune responses  of 
several inbred and random-bred strains of guinea pigs  to  three  linear polypeptide 
antigens: (a)  GA, poly-~-(L-glutamic acid [60%],  L-alanine [40%]);  (b)  GT, poly-a- 
(r~-glutamic acid  [50%],  L-tyrosine [50%]);  and  (c)  GAT,  poly-a-(L-glutamic acid 
[60%], L-alanine [30%], L-tyrosine [10%]). 
Our data demonstrate that the ability to develop immune responses to both 
GA and GT is genetically determined in guinea pigs and inherited as separate 
autosomal dominant traits.  GAT, however,  which contains both  GA and GT 
determinants among others,  is immunogenic in all guinea pigs tested. 
Materials and Methods 
Polymers.--GA, mol wt 43,000, was obtained from Pilot Chemicals Inc., division of  New 
England Nuclear Corp., Boston, Mass. GT, mol wt 14,500, was obtained from Miles Labora- 
tories, Inc., Elkhart, Ind. GAT, tool wt 25,000, was a gift of Dr. P. H. Maurer. 
Animals.--Inbred strain 2 and strain 13 guinea pigs and the outbred N.I.H. multipurpose 
guinea pigs were obtained from the Animal Production Unit, National Institutes of Health, 
Bethesda, Md. Outbred Hartley strain guinea pigs were obtained from Camm Research In- 
stitute, Inc., Wayne, N.J.,  and from the Animal Production Unit, N.I.H.  Coulsen strain 
guinea pigs were a gift from the Agriculture Research Service, U. S. Department of Agriculture. 
All guinea pigs used in these studies weighed between 250 and 450 g. 
Preparation of Rabbit Anti-Guinea Pig Gamma Globulin.--Rabbit  anti-guinea pig gamma 
globulin antisera used as the precipitating reagent in the antibody assay were produced in 
female New Zealand white rabbits weighing 2.5 kg. Each rabbit received 2.5 mg guinea pig 
gamma globulin (purified  as described previously [12]) emulsified in complete Freund's ad- 
juvant (Difco Laboratories, Detroit, Mich.) and distributed in the four footpads. The rabbits 
were subsequently injected every 2 wk with 1.0 mg of the guinea pig gamma globulin emulsi- 
fied in incomplete adjuvant distributed subcutaneously in the flanks. The rabbits were bled 
by cardiac puncture at 5, 7, and 9 wk after the initial immunization. The pooled sera con- 
mined 4 mg precipitating antibody/ml. 
Immunization  of Guine.~ Pigs.--Solutions of the synthetic antigens in 0.015 ~  phosphate 
buffer,  pH 7.5, containing 0.15 M NaC1 (PBS)  at the desired concentration were emulsified 
in an equal volume of complete Freund's adjuvant containing  0.5 mg/ml Mycobacterium butyri- 
cure (Difco Laboratories). Each guinea pig received 0.4 ml of the emulsion distributed equally 
in the four footpads. 
Skin Te~ts.--3 wk after immunization the guinea pigs were injected intradermally with 50 
#g of the immunizing polymer in 0.1 ml normal saline. Animals immunized with adjuvant 
alone were similarly skin tested to evaluate the degree  of nonspecific irritation produced by 
these peptides. The injection sites were examined after 24 hr. Since nonspecific irritation up 
to 8 mm in diameter was occasionally observed, erythema and induration greater than 8 mm 
in diameter was considered a positive skin test, and the intensity of the reactions was graded 
as follows: +, 8-15 mm greatest diameter; ++,  15-25 mm greatest diameter; +++,  >25 
mm greatest diameter. 
Antibody  Assay.--The guinea pigs were bled from the retro-orhital venous plexus 3 wk 
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the immunizing  polymer using a  modified Farr-type assay (13). Radioactive ligands were 
made by iodinating GT and GAT polymers with 125I using the chloramine-T  method (14). 
GAT-125I was used to assay for both anti-GAT and anti-GA antibody activity. A mixture of 
0.025 ml of the appropriate ligand (5-10 m#g)  and 0.025 ml of a 1:5 dilution in PBS of the 
serum to be tested was placed at 4°C. Mter 30 min, 0.05 ml of the rabbit anti-gulnea pig 
gamma globulin diluted 1:1  with PBS was added. After an additional 30 rain at 4°C, the 
samples were centrifuged  at 2500 rpm for 15 min, and 0.05 ml of the resulting supernates 
were counted in a Packard gamma spectrometer (Packard Instrument Co., Downers  Grove: 
Ill.). The radioactivity remaining in the supernates of the test samples was compared to the 
radioactivity remaining when normal guinea pig serum was used, and the data expressed as 
per cent antigen bound according to the formula: 
(1  --  cpm_!n  supernate from test sera  %  binding  cpm in supernate from normal sera] X  100. 
For both the GT-e~I and GAT-~sI ligands used in this study, a comparison of the binding 
values of a panel of control nonimmune sera indicated that greater than 10%  antigen binding 
was needed to demonstrate the presence of specific antibody in our test antisera. This value is 
greater than  the difference in binding  observed between  any two nonimmune  sera, and is 
approximately three standard deviations from the mean per cent binding of all nonimmune 
sera tested. 
RESULTS 
When immunized with 500 #g of a random copolymer of L-glutamic acid and 
L-alanine (GA), all inbred strain 2 guinea pigs tested respond with both delayed 
hypersensitivity and serum antibody to GA (Table I). An adequate immuniz- 
ing  dose  of  GA  is needed  to  elicit uniform  responsiveness,  for  only  73 %  of 
strain  2  guinea pigs respond when  immunized with  100  #g of  GA with weak 
delayed skin reactions. Inbred strain 13  guinea pigs, on the other hand, do not 
respond to immunization with 500/zg of GA. They do not demonstrate delayed 
skin reactivity and their sera have no detectable anti-GA antibody (Fig. 1). 
All F1  hybrid  offspring  resulting  from  the  mating  of  strain  2  male  with 
strain 13 female guinea pigs respond to immunization with 500 #g GA, demon- 
strating that the ability to respond to GA is inherited as an autosomai dominant 
trait.  Their  delayed skin reactions are,  as those in  the  strain 2,  of moderate 
intensity. Their mean serum antigen binding, 31.2 %,  is somewhat lower than 
the 41.5 %  mean antigen binding seen in the sera of strain 2  animals, but this 
difference  is  not  statistically significant.  A  variable  percentage  of  random- 
bred Harttey strain guinea pigs develop delayed-type hypersensitivity to  GA 
(Table I). The response rate to GA inmmnization depends upon the source of 
the animals. Thus, in our experiments, 90 % of the Hartley guinea pigs obtained 
from  the N.I.H.  Animal Production  Unit  (N.I.H.  Hartleys)  demonstrate  de- 
layed skin reactivity to  GA 3  wk after a  single immunization with  100/~g  of 
GA.  However,  under  the  same  conditions,  less  than  60%  of  Hartley guinea 
pigs obtained from Camm  Research Institute,  Inc.  (Camm Hartleys) develop 
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TABLE  I 
Immune Responses of Guinea Pigs to GA 
Strain  Immunizing  No. of  No. of re-  Intensity  % Antigen bound§  of skin 
dose  animals  sponders*  reactions  Responder  Nonresponder 
gg  Mean  (8.g)  Mean  (S.B) 
2  100  26  19  -4-  21.0  (2.21)  -- 
2  500  11  11  q-q-  41.5  (4.00)  -- 
13  500  10  0  --  --  1.1  (0.72) 
(2 X  13)F1  500  6  6  q-q-  31.2  (6.83)  -- 
N.I.H.  100  20  18  A-+q-  64.1  (4.22)  6.0  (0.0) 
Harfley 
Camm  100  54  31  q-q-q-  49,8  (3.07)  7.0  (1.15) 
Harfley 
Camm  500  20  9  q-q-q-  37,3  (5.15)  2.7  (1.04) 
Harfley 
N.I.H.  500  30  1  q-  27,7  (0.0)  3.89  (1.03) 
multipur- 
pose 
* Responders are those animals exhibiting delayed skin reactivity after an intradermal in- 
jection of 50#g of GA 3 wk after immunization. 
Delayed skin reactions read 24 hr after injection are graded according to the extent of 
erythema and induration as follows: --  =  <8 mm greatest diameter; q-  =  8-15 mm greatest 
diameter; q- q- =  15-25 mm greatest diameter;  q- + q-  =  > 25 mm greatest diameter. 
§ The amount of GAT-12~I bound by a  1:5 dilution of the test serum  compared to the 
amount bound by a 1 : 5 dilution of normal serum. The assay is described in detail in Materials 
and Methods. 
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Fro.  1.  Antibody response to 0.5 mg GA in individual inbred strain 2 and strain 13 guinea 
pigs expiessed as the per cent binding of GAT-125I, 0.15 ~g/ml, by a 1 : 10 dilution of antiserum 
(see Materials and Methods). 462  GENETIC  CONTROL  OF  IMMUNE  RESPONSIVENESS 
Among Hartley animals, also, there is an excellent correlation between the 
ability to respond to GA immunization with delayed hypersensitivity and the 
ability to produce antibody directed against  GA.  All sera from "responder" 
guinea  pigs  (i.e.,  those  animals  demonstrating  delayed  hypersensitivity  to 
the immunizing antigens)  contain anti-GA antibody (Fig. 2).  Sera from most 
"nonresponder" Hartley guinea pigs do not  contain  any detectable anti-GA 
antibody. The few that do have very low levels. 
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FIG. 2. Antibody response to 0.1 mg GA in individual responder (skin test positive) and 
nonresponder (skin test negative) random-bred Camm Hartley guinea pigs expressed as the 
per cent binding of GAT-125I,  0.15 ~g/ml, by a 1:10 dilution of antiserum (see Materials and 
Methods). 
A fivefold increase in the immunizing dose of GA does not increase either the 
response rate or the level of antibody produced in Hartley responders. In fact, 
increasing the immunizing dose from 100 to 500/zg results in a slight decrease 
from 58  to 42 %  responders and a  drop in their mean serum antigen binding 
from 49.8  to 37.3 %.  Both of these differences, however, are not statistically 
significant. 
In contrast to the rate of GA responsiveness in Hartley animals, the random- 
bred pigmented N.I.H. multipurpose guinea pigs demonstrate a very low GA 
response rate. Only one GA responder was found among the 30 animals im- 
munized with 500/~g GA. 
When immunized with 500/zg  GT,  all strain  13 guinea pigs respond with 
moderately strong delayed-hypersensitivity skin reactions and significant levels 
of circulating anti-GT antibody (Table II). Inbred strain 2 guinea pigs, on the 
other hand, do not respond with either delayed hypersensitivity or circulating H.  G.  BLUESTEIN~  I.  GREEN~  AND  B.  BENAC:ERRAF  463 
antibody after immunization with 500 ~g GT (Fig. 3). All F1 hybrid offspring 
from rantings  of strain  13  males with  strain  2  females respond to immuniza- 
tion with 500/zg GT. Thus, the ability to respond to GT is also inherited as an 
autosomal dominant trait.  The delayed skin reactions to GT observed in the 
F1  hybrids  are,  as  in  strain  13  animals,  moderately  intense.  The  anfi-GT 
antibody level in the sera of the F1 hybrids,  19.8%  mean antigen binding,  is 
considerably lower than  the 38.1%  mean  antigen binding produced in strain 
13 guinea pigs similarly immunized. 
TABLE II 
Immune Responses of Guinea Pigs to GT 
Strain  Immunizing  No. of  No. of re-  IntensltYof  skin  % Antigen bound§ 
dose  animals sponders*  reaction~  Re.ponder  Nonresponder 
,g  ~lean  (s.B)  M,an  (S.B) 
13  100  12  6  :i:  14.7  (2.33)  -- 
13  500  13  13  ++  42.7  (3.79)  -- 
2  500  10  0  -  --  4.6  (1.18) 
(13 >( 2)F1  500  6  6  ++  19.8  (1.51)  -- 
N.I.H. Hartley  100  23  11  ++  32.5  (6.97)  5.2  (1.43) 
Camm Hartley  100  88  55  ++  25.0  (2.25)  5.9  (0.92) 
Carom Hartley  500  18  15  +++  48.2  (4.33)  10.2  (3.35) 
N.I.H. multipur-  500  65  56  ++  66.2  (2.37)  4.71  (1.31) 
pose 
* Responders  are  those animals  exhibiting delayed skin reactivity after  an intradermal 
injection of 50/~g of GT 3 wk after immunization. 
:~ Delayed skin reactions read 24 hr after injection are graded according to the extent  of 
erythema and induration as described in Table I. 
§ The amount of GT-125I bound  by a  1:5 dilution  of the test serum  compared  to the 
amount bound by a 1:5 dilution of normal serum. The assay is described in detail in Materials 
and Methods. 
When the immunizing dose of GT is decreased significantly, the response of 
inbred  strain  13  guinea  pigs  becomes  inconsistent,  Only  about  half  of  the 
strain  13  animals  immunized  with  100  /zg of  GT  demonstrate  delayed  skin 
reactivity to GT. In addition,  their positive reactions are quite weak and the 
level of anti-GT antibody produced is very low. 
After immunization  with  100 ~g  GT in  complete Freund's  adjuvant,  from 
50-60% of Hartley guinea pigs, depending upon their source, develop delayed- 
hypersensitivity  skin  reactions  when  challenged  intradermally  with  50  /zg 
GT (Table II). Both Carom  and  N.I.H. Hartley  responder  guinea  pigs  pro- 
duce relatively low levels of serum anti-GT antibody at this immunizing dose. 
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(32.5%)  is  somewhat  higher  than  that  found  in  Carom  Hartleys  (25.0%), 
but this difference is not statistically significant. 
There is  a  correlation between responder status,  after immunization with 
100/~g GT, and the presence of circulating antibody. The sera from most Carom 
Hartley nonresponders are devoid of detectable anti-GT antibody, while the 
sera  from  most  responders  contain  a  significant  amount  of  it.  There  are, 
however, a  few nonresponders producing detectable anti-GT antibody,  albeit 
at  very low  levels,  and  several  responder  guinea  pigs  that  do  not  produce 
detectable antibody. 
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Fro.  3.  Antibody response to 0.5 mg GT in individual inbred strain 2 and strain 13 guinea 
pigs expressed as the per cent binding of GTJ25I, 0.1 #g/ml, by a  1 : 10 dilution of antiserum 
(see Materials and Methods), 
Increasing the immunizing dose of GT from 100  to 500 #g per animal re- 
sults in a  somewhat higher response rate of 80%  and,  concomitantly, higher 
serum  antigen-binding  levels.  The increase  from  25%  mean  serum  antigen 
binding after immunization with 100 #g GT to 48 %  after immunization with 
500/~g  GT in  Carnm Hartleys is  statistically significant.  At  the 500 #g GT 
immunizing dose there is a good correlation between responder status and the 
presence  of  circulating  anti-GT  antibody  (Fig.  4).  All  responders  produce 
detectable anti-GT antibody.  Of the  three nonresponders in  this group,  the 
serum of one has no detectable anti-GT antibody, while the sera of the other 
two have very low GT binding levels. 
N.I.H.  multipurpose guinea pigs have a very high rate of GT responsive- 
ness. About 84 % of those immunized with 500 t~g GT respond with both de- 
layed hypersensitivity and high levels of anti-GT antibody. The 66.2 %  mean H.  G.  BLUESTEIN~ I.  GREEN, AND  B.  BENACERRAF  465 
serum antigen binding of N.I.H. multipurpose GT responders is considerably 
greater  than  the anti-GT levels produced  by  any  of the  other  strains  tested. 
TABLE III 
Immune Responses of Guinea Pigs to GA T 
Immunizing  No. of  No. of  Intensity  of 
Strain  dose  animals  responders*  skin reactions  % Antigen bound§ 
gg  Mean  (&B) 
2  I00  7  7  ++  72.6  (5.71) 
2  500  5  5  ++  77.3  (3.00) 
13  100  10  10  ++  49.0  (4.65) 
Carom Hartley  100  19  19  +++  76.5  (2.19) 
Coulsen  100  8  8  +++  72.8  (3.86) 
N.I.H. multi-  100  26  26  ++  53.9  (3.39) 
purpose 
* Responders are those animals exhibiting delayed skin reactivity after an intradermal in- 
jection of 50#g of GAT 3 wk after immunization. 
Delayed skin reactions read 24 hr after injection are graded  according to the extent of 
erythema and induration as described in Table I. 
§ The amount of GAT-125I bound  by a  1:5  dilution  of the test serum compared  to the 
amount bound by a 1:5  dilution  of normal serum. The assay is described in Materials and 
Methods. 
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Fro. 4.  Antibody  response  to 0.5  mg GT  in  individual  responder  (skin test  positive) 
and nonresponder  (skin test negative)  Carom Hartley guinea pigs expressed as the per cent 
binding of GT-125I, 0.1 #g/ml, by a 1:10 dilution of antiserum  (see Materials  and Methods.) 
None of the N.I.H. multipurpose GT nonresponders produced any detectable 
anti-GT antibody. 
After immunization with  100  /zg  GAT,  all  guinea pigs  respond  with  both 
delayed  hypersensitivity  and  circulating  anti-GAT  antibody  (Table  III). 
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Among the 85  guinea pigs from five different strains tested,  there is not a 
single nonresponder to GAT. Between the two inbred strains, strain 2 guinea 
pigs  produce  significantly higher  anti-GAT  antibody levels.  Increasing  the 
immunizing dose fivefold did not abolish this difference. Among the different 
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FIo.  5.  Frequency of responsiveness to GA, GT, and GAT in inbred strain 2  and strain 
13 and random-bred Hartley  strain guinea pigs obtained from two different sources. 
random-bred strains immunized with GAT, the mean serum antigen-binding 
levels produced by Hartley and Coulsen guinea pigs are similar to the level 
found in strain 2 guinea pigs. The N.I.H. multipurpose guinea pigs,  however, 
like strain 13 animals, produce significantly lower levels of anti-GAT antibody. 
The results of our studies on the immunogenicity of GA, GT, and GAT are 
summarized in Fig. 5.  Strain 2 guinea pigs all respond to GA and GAT but 
not to GT.  Strain  13  guinea pigs respond to GT and GAT but not to GA. 
Among the  outbred  Hartley animals,  all respond  to  GAT,  but  a  variable 
percentage, depending upon their source, respond to GA and GT. H.  G.  BLUESTEIN,  I.  GREEN,  AND  B.  BENACERRAF  467 
DISCUSSION 
Inbred  strain 2 guinea  pigs all respond  to immunization  with  an adequate 
dose of GA  with both cellular and humoral  immunity.  Inbred  strain 13 guinea 
pigs, on the other hand, are unable to make either cellular or humoral immune 
responses  when  similarly  immunized.  Thus,  it  appears  that  the  ability  to 
respond immunologically to  GA is  a  genetically determined trait  that is  ex- 
pressed  as  an  "all-or-none" phenomenon within  the  detection limits  of  our 
assays. 
Our  observations  that  all  F1  hybrid progeny,  resulting  from matings  be- 
tween  these  two  strains,  respond  to  GA  immunization  in  a  manner  similar 
to  their strain  2  parent  demonstrate  the  dominant  character  of  the  genetic 
trait  determining  GA  responsiveness.  This  observation proves,  furthermore, 
that we are not dealing with a sex-linked trait, for if it were, the male offspring 
of matings between strain 2 males and strain 13 females would be nonresponders. 
Hence, the ability to respond immunologically to GA is inherited as an auto- 
somal dominant trait. 
The  pattern  of  GA  responsiveness  among  the  several  guinea  pig  strains 
closely parallels  the pattern  of PLL responsiveness  (8).  Both PLL and  GA 
are immunogenic in all strain 2 and some Hartley guinea pigs but not in any 
strain 13 animals. It has already been shown, however, that immune respon- 
siveness to  GA is not controlled by the PLL gene (15).  As we demonstrate 
in greater detail in the subsequent paper (16), GA and PLL responsiveness are 
dissociated in some Hartley guinea pigs. There are, therefore, separate genes 
governing the ability to develop immune response to these two polymers. 
In contrast to the pattern of GA responsiveness among guinea pig strains, 
all strain  I3  guinea pigs respond with  both  cellular and  humoral immunity 
after immunization with  GT in  complete Freund's  adjuvant,  while  strain  2 
animals are completely unresponsive. As is the case with GA responsiveness, 
however, all the F1 hybrid progeny from matings of these two strains are GT 
responders,  thus  demonstrating  that  immune  responsiveness  to  GT  is  also 
inherited as  an  autosomal dominant trait.  Furthermore, in studies  to be re- 
ported of the responsiveness of the backcross progeny of (2  X  13)F1  animals 
mated to the appropriate nonresponder parental strain, it will be shown that 
separate single autosomal dominant genes control responsiveness to  GA and 
GT respectively in strains 2 and 13.  2 
The ability to mount an immune response directed against  GAT does not 
appear to be under such simple genetic control. Unlike GA or  GT,  GAT is 
immunogenic in  all  guinea pigs  tested.  Some  characteristics of  the immune 
response  to  GAT,  however,  do  seem  to  be  genetically influenced.  In  fact, 
2  Bluestein, H.  G., L. Ellman, I.  Green, and B. Benacerraf. Specific  immune response 
genes of the guinea pig. IV. Linkage of GA and GT immune response genes to histocompafi- 
bility genotype of inbred guinea  pigs. Manuscript in preparation. 468  GENETIC  CONTROL  OF  IMMUNE  RESPONSIVENESS 
both  strain  13  and N.I.H.  multipurpose guinea pigs produce distinctly lower 
amounts of anti-GAT antibody than do the other strains.  These two strains 
have in  common a  very high  rate  of GT responsiveness and,  perhaps  more 
importantly,  a  very low percentage of GA responders.  Structurally,  GAT is 
GA with  10%  of its alanine residues replaced with tyrosine groups. The de- 
creased antibody levels in the strain  13 and N.I.H. multipurpose guinea pigs 
may be due in part  to their inability to recognize or respond to the GA de- 
terminants which must comprise a large part of the GAT molecule. Evidence 
to support this hypothesis will be presented subsequently in a more detailed 
study of the genetically determined variations in immune responses to GAT? 
The immunogenicity of  GT,  GA,  and  GAT in inbred and Hartley guinea 
pigs has been reported on previously by other workers  (17,  18).  Ben-Efraim 
et al. reported that GT was immunogenic in strain 13 but not strain 2 guinea 
pigs (17). However, they failed to observe responsiveness to GT in ( 2 X  13)F1 
animals. This was probably the result of immunizing with only 100 #g of GT 
which, as we demonstrate in this study, is a submaximal immunizing dose. 
Ben-Efraim and Maurer (18)  have reported on the immunogenicity of GA 
and GAT in strain 2, strain 13, and Hartley guinea pigs using the same poly- 
mers we have used. Their results are consistent with ours with the exception 
that  they did not observe uniform responsiveness to GA in strain 2 animals, 
perhaps  because  they immunized  with  100  ~g  of  the  antigen  which,  as  we 
have shown in this study, does not elicit maximal responses. The lack of uni- 
form delayed-hypersensitivity responses to GAT in both of their studies may 
be due to the use,  by these workers,  of adjuvant  containing Mycobacterium 
tuberculosis (H37Rv)  at 10 mg/ml. In certain situations this adjuvant has been 
shown to suppress immune responses to synthetic polypeptide antigens  (19). 
We have noted this phenomenon with both GT and CAT.  4 
We have demonstrated in this study the  existence of two distinct genetic 
systems  controlling  immune  responsiveness  of  guinea  pigs  to  two  different 
synthetic polypeptide antigens,  GA  and  GT.  Since like the PLL  gene these 
are dominant genetic traits,  the lack of responsiveness in nonresponders can- 
not  be  attributed  to  tolerance,  that  is,  a  cross-reactivity of  the  synthetic 
antigen with a component of the nonresponding guinea pig. The data reported 
in this paper and also that to be presented demonstrate that the GA gene and 
the GT gene behave as unique autosomal dominant specific immune response 
genes similar in their properties to the PLL gene. 
Bluestein, H. G., I. Green, P. H. Maurer, and B. Benacerraf. Specific  immune response 
genes of the guinea pig. III. Influence  of the GA and GT immune response  genes on the speci- 
ficity of cellular and humoral immune responses to the terpolymer of L-glutamic acid, L-ala- 
nine, and L-tyrosine  (GAT). Manuscript in preparation. 
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SUMMARY 
The immunogenicity of three random  copolymers of amino  acids  with  L- 
glutamic  acid  and L-alanine  (GA),  L-glutamic acid  and L-tyrosine (GT),  or 
L-glutamic acid,  L-alanine,  and L-tyrosine (GAT),  administered in  complete 
Freund's  adjuvant,  was  studied  in  several  inbred  and  random-bred  guinea 
pig strains. The animals were tested for delayed sensitivity and their sera were 
assayed for the presence of antibody directed against the immunizing polymer. 
All of the guinea pigs developing delayed hypersensitivity also had significant 
antibody levels in their sera. 
Inbred strain 2 guinea pigs responded to immunization with GA, but failed 
to form detectable responses to  GT. Inbred strain  13  animals,  on the other 
hand, responded to GT, but not to GA. The (2 X  13)F1 hybrids responded to 
both GA and GT with both delayed hypersensitivity and circulating antibody. 
Thus,  the ability of these inbred guinea pigs to respond immunologically to 
GA or GT is controlled by distinct autosomal dominant genes. 
A  variable  percentage  of  random-bred  guinea  pigs,  depending  on  their 
source  as  well  as  their  strain,  responded  to  immunization  with  GA  and 
with GT. 
All guinea pigs, both inbred and random bred, responded to immunization 
with  GAT. The ability to respond immunologicaily to GAT,  therefore, does 
not seem to be under simple genetic control. However, the levels of anti-GAT 
antibody found in the sera of animals  lacking the ability to respond  to GA 
were much lower than those detected in GA responder animals. 
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